Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • Kidney Week 2024
    • CHEST 2024
    • ACR Convergence 2023
    • Kidney Week 2023
    • ObesityWeek 2023
    • IDWeek 2023
    • CHEST 2023
    • MDS 2023
    • IAS 2023
    • ACP 2023
    • AAN 2023
    • ACC / WCC 2023
    • AAAAI Meeting 2023
    • ACR Convergence 2022
    • Kidney Week 2022
    • AIDS 2022
Article

A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds

Ron Waksman, MD, FACC, FSCAI
Cleveland Clinic Journal of Medicine December 2017, 84 (12 suppl 4) e20-e24; DOI: https://doi.org/10.3949/ccjm.84.s4.05
Ron Waksman
Director, Cardiovascular Research Advanced Education, MedStar Heart and Vascular Institute, Washington, DC
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: [email protected]
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 84 no. 12 suppl 4 e20-e24
DOI 
https://doi.org/10.3949/ccjm.84.s4.05
PubMed 
29281608

Published By 
Cleveland Clinic Journal of Medicine
Print ISSN 
0891-1150
Online ISSN 
1939-2869
History 
  • Published online January 1, 2017.

Copyright & Usage 
Copyright © 2017 The Cleveland Clinic Foundation. All Rights Reserved.

Author Information

  1. Ron Waksman, MD, FACC, FSCAI⇑
  1. Director, Cardiovascular Research Advanced Education, MedStar Heart and Vascular Institute, Washington, DC
  1. Correspondence:
    Ron Waksman, MD, MedStar Washington Hospital Center, 110 Irving St., NW, RM 6D15E, Washington, DC 20010; ron.waksman{at}medstar.net.
PreviousNext
Back to top

In this issue

Cleveland Clinic Journal of Medicine: 84 (12 suppl 4)
Cleveland Clinic Journal of Medicine
Vol. 84, Issue 12 suppl 4
1 Dec 2017
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cleveland Clinic Journal of Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
(Your Name) has sent you a message from Cleveland Clinic Journal of Medicine
(Your Name) thought you would like to see the Cleveland Clinic Journal of Medicine web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
Ron Waksman
Cleveland Clinic Journal of Medicine Dec 2017, 84 (12 suppl 4) e20-e24; DOI: 10.3949/ccjm.84.s4.05

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
A new generation of drug-eluting stents: Indications and outcomes of bioresorbable vascular scaffolds
Ron Waksman
Cleveland Clinic Journal of Medicine Dec 2017, 84 (12 suppl 4) e20-e24; DOI: 10.3949/ccjm.84.s4.05
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Linkedin Share Button

Jump to section

  • Article
    • ABSTRACT
    • GREAT EXPECTATIONS
    • PROBLEMS WITH DURABLE POLYMER STENTS
    • BIORESORBABLE POLYMERS EMERGE
    • THE RATIONALE FOR BIORESORBABLE STENTS
    • ABSORB II STUDY RESULTS RAISE QUESTIONS
    • BIORESORBABLE SCAFFOLDS PIPELINE
    • SUMMARY
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • New treatments for peripheral artery disease
  • Functional tricuspid regurgitation: Feasibility of transcatheter interventions
  • A practical approach to the cholesterol guidelines and ASCVD prevention
Show more Article

Similar Articles

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2025 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire